Gaucher Disease and Its Treatment Options

@article{Bennett2013GaucherDA,
  title={Gaucher Disease and Its Treatment Options},
  author={Lunawati L. Bennett and D. Mohan},
  journal={Annals of Pharmacotherapy},
  year={2013},
  volume={47},
  pages={1182 - 1193}
}
  • Lunawati L. Bennett, D. Mohan
  • Published 2013
  • Medicine
  • Annals of Pharmacotherapy
    • Objective: To review the epidemiology, pathophysiology, and treatments of Gaucher disease (GD), focusing on the role of enzyme replacement therapy (ERT), andsubstrate reduction therapy (SRT). Data Sources: A literature search through PubMed (1984-May 2013) of English language articles was performed with terms: Gaucher’s disease, lysosomal storage disease. Secondary and tertiary references were obtained by reviewing related articles. Study Selection and Data Extraction: All articles in English… CONTINUE READING
    View on SAGE
    ncbi.nlm.nih.gov
    61 Citations
    Highly Influential Citations
    4
    Background Citations
    22
    Methods Citations
    1
    61 Citations
    Citation Type

    Citation Type

    Liver involvement in patients with Gaucher disease types I and III
    • 1
    Improvement In Symptoms Of Gaucher's Disease By Enzyme Replacement Therapy.
    • 2
    Enzyme Replacement or Substrate Reduction? A Review of Gaucher Disease Treatment Options
    • 17
    GBA, Gaucher Disease, and Parkinson’s Disease: From Genetic to Clinic to New Therapeutic Approaches
    • 33
    • PDF
    Effect of Substrate Reduction Therapy in Comparison to Enzyme Replacement Therapy on Immune Aspects and Bone Involvement in Gaucher Disease
    • 1
    • PDF
    Choroba Gauchera – zalecenia dotyczące rozpoznawania, leczenia i monitorowania
    Induced Pluripotent Stem Cell Modeling of Gaucher’s Disease: What Have We Learned?
    • 5
    • PDF
    Less Is More: Substrate Reduction Therapy for Lysosomal Storage Disorders
    • 42
    • PDF
    Treatment of profound thrombocytopenia in a patient with Gaucher disease type 1: Is there a role for substrate reduction therapy
    • 2
    Challenges of Enzyme Replacement Therapy: Poor Tissue Distribution in Lysosomal Diseases Using Pompe Disease as a Model

    References

    SHOWING 1-10 OF 96 REFERENCES
    Gaucher's Disease: A Review
    • 38
    New directions in the treatment of Gaucher disease.
    • 97
    • PDF
    Gaucher disease: pathological mechanisms and modern management
    • 264
    Clinical and genetic characteristics of Gaucher disease according to phenotypic subgroups
    • 24
    Gaucher disease: clinical profile and therapeutic developments
    • T. Cox
    • Medicine
    • Biologics : targets & therapy
    • 2010
    • 98
    • Highly Influential
    • PDF
    Gaucher disease: lessons from a decade of therapy.
    • 50
    An evidence-based review of the potential benefits of taliglucerase alfa in the treatment of patients with Gaucher disease
    • 27
    • Highly Influential
    • PDF
    Management of non-neuronopathic Gaucher disease with special reference to pregnancy, splenectomy, bisphosphonate therapy, use of biomarkers and bone disease monitoring
    • 108
    Gaucher disease: new developments in treatment and etiology.
    • 23
    Epidemiology and natural history of Gaucher's disease.
    • A. Mehta
    • Medicine
    • European journal of internal medicine
    • 2006
    • 74